Tratamento das hepatites virais B e D (2003)
- Authors:
- USP affiliated authors: SILVA, LUIZ CAETANO DA - FM ; CARRILHO, FLAIR JOSE - FM ; NITA, SUZANE KIOKO ONO - FM
- Unidade: FM
- Subjects: HEPATITE VIRAL HUMANA; HEPATITE B
- Language: Português
- Imprenta:
- ISBN: 85-7378-138-6
- Source:
- Título: Hepatites agudas e crônicas
-
ABNT
SILVA, Luiz Caetano da et al. Tratamento das hepatites virais B e D. Hepatites agudas e crônicas. Tradução . São Paulo: Sarvier, 2003. . . Acesso em: 10 mar. 2026. -
APA
Silva, L. C. da, França, A. V. C., Nita, S. K. O., Martineli, A. de L. C., & Carrilho, F. J. (2003). Tratamento das hepatites virais B e D. In Hepatites agudas e crônicas. São Paulo: Sarvier. -
NLM
Silva LC da, França AVC, Nita SKO, Martineli A de LC, Carrilho FJ. Tratamento das hepatites virais B e D. In: Hepatites agudas e crônicas. São Paulo: Sarvier; 2003. [citado 2026 mar. 10 ] -
Vancouver
Silva LC da, França AVC, Nita SKO, Martineli A de LC, Carrilho FJ. Tratamento das hepatites virais B e D. In: Hepatites agudas e crônicas. São Paulo: Sarvier; 2003. [citado 2026 mar. 10 ] - Cinética viral e resultados tardios do tratamento com consensus interferon a (CIFN) e ribavirina (RB) em pacientes com hepatite crônica C (HC-C) previamente resistentes à associação com IFN a e RB
- Rapid and profound drop HCV RNA viremia induced by high dose of consensus IFN (CIFN) just before starting pegylated interferon (PEG-IFN) plus ribavirin (RBV) in chronic hepatitits C patients (pts) previously resistant to combined therapy (IFN+RBV): preliminary report
- Unpredictable outcome in lamivudine (LAM): resistant patients under high daily doses & early effects of combined therapy of lam plus pegylated interferon
- Searching for chronic hepatitis B patients in a low prevalence area: role of racial origin
- A phylogenetic study of hepatitis B virus in chronically infected Brazilian patients of Western and Asian descent
- High rate of sustained response to consensus interferon plus ribavirin in chronic hepatitis C patients resistant to alpha-interferon and ribavirin: a pilot study
- A twelve-week period of follow-up after an end of treatment response (ETR) in patients with chronic hepatitis C (CH-C) submitted to combined therapy is a reliable period to characterize a sustained response
- Rapid and profound drop of HCV RNA viraemia induced by high dose of consensus interferon just before starting pegylated interferon plus ribavirin in chronic hepatitis C patients previously resistant to combined therapy:: preliminary report.
- A twelve-week period of follow-up after an end-of-treatment response in patients with chronic hepatitis C submitted to combined therapy is a reliable period to characterize a sustained response.
- A prospective study of the prevalence of hepatitis B and C virus co-infection among patients with chronic renal disease under hemodialysis
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
